hellotayssir/FinQA_TAT-QA_financial_finetuning_dataset huggingface dataset:
The three levels are described below:
Level 1 Inputs – Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;
Level 2 Inputs – Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly;
Level 3 Inputs – Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.
The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair value because of
the short maturity of those instruments. The carrying amount of the Company’s financial assets and liabilities, such as cash, accounts payable and accrued expenses approximate their fair value because of the short maturity of those instruments.
Transactions involving related parties cannot be presumed to be carried out on an arm’s-length basis, as the requisite conditions of competitive, free-market dealings
may not exist. Representations about transactions with related parties, if made, shall not imply that the related party transactions were consummated on terms equivalent to
those that prevail in arm’s-length transactions unless such representations can be substantiated.
The assets or liability’s fair value measurement within the fair value hierarchy is based upon the lowest level of any input that is significant to the fair value measurement. The following table provides a summary of financial instruments that are measured at fair value as of December 31, 2019.
Table:
 |  | Fair Value Measurement Using |  |  | 
 | Carrying Value | Level 1 | Level 2 | Level 3 | Total
Marketable securities | 0 | 0 | 0 | 0 | 0
Derivative warrants liabilities | $(332,222) | $- | $- | $(332,222) | $(332,222)


Question: What is the total Level 3 marketable securities and derivative warrants liabilities? 
Answer: 332222
Calculation: 332,222 + 0
performance graph the graph below compares the cumulative total shareholder return on pmi's common stock with the cumulative total return for the same period of pmi's peer group and the s&p 500 index . the graph assumes the investment of $ 100 as of december 31 , 2012 , in pmi common stock ( at prices quoted on the new york stock exchange ) and each of the indices as of the market close and reinvestment of dividends on a quarterly basis . date pmi pmi peer group ( 1 ) s&p 500 index .

Table:
date | pmi | pmi peer group ( 1 ) | s&p 500 index
december 31 2012 | $ 100.00 | $ 100.00 | $ 100.00
december 31 2013 | $ 108.50 | $ 122.80 | $ 132.40
december 31 2014 | $ 106.20 | $ 132.50 | $ 150.50
december 31 2015 | $ 120.40 | $ 143.50 | $ 152.60
december 31 2016 | $ 130.80 | $ 145.60 | $ 170.80
december 31 2017 | $ 156.80 | $ 172.70 | $ 208.10
( 1 ) the pmi peer group presented in this graph is the same as that used in the prior year , except reynolds american inc .
was removed following the completion of its acquisition by british american tobacco p.l.c .
on july 25 , 2017 .
the pmi peer group was established based on a review of four characteristics : global presence ; a focus on consumer products ; and net revenues and a market capitalization of a similar size to those of pmi .
the review also considered the primary international tobacco companies .
as a result of this review , the following companies constitute the pmi peer group : altria group , inc. , anheuser-busch inbev sa/nv , british american tobacco p.l.c. , the coca-cola company , colgate-palmolive co. , diageo plc , heineken n.v. , imperial brands plc , japan tobacco inc. , johnson & johnson , kimberly-clark corporation , the kraft-heinz company , mcdonald's corp. , mondel z international , inc. , nestl e9 s.a. , pepsico , inc. , the procter & gamble company , roche holding ag , and unilever nv and plc .
note : figures are rounded to the nearest $ 0.10. .

Question: what is the growth rate in pmi's share price from 2014 to 2015?
Answer: 13.4%
Calculation: subtract(120.40, 106.20), divide(#0, 106.20)
NOTE 11 – STOCK COMPENSATION
The Company sponsors a stock-based incentive compensation plan known as the 2013 Equity Compensation Plan (the “Plan”), which was established by the Board of Directors of the Company in June 2013. A total of 500,000 shares were initially reserved for issuance under the Plan. The Plan was amended several times since then to eventually increase the authorized shares to 2,500,000 as of December 31, 2019. A total of 1,624,221 shares of common stock underlying options were outstanding at December 31, 2019. The Company had 236,614 remaining shares available to grant under the Plan at December 31, 2019.
The Plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation rights, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company’s Board or Compensation Committee believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and may be exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the Plan.
The compensation cost that has been charged against income related to options for the years ended December 31, 2019 and 2018, was $1,687,745 and $1,317,904, respectively. No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented.
The Company had the following option activity during the years ended December 31, 2019 and 2018:
Of the options outstanding at December 31, 2019, 1,143,637 were exercisable with a weighted average contractual life of 1.9 years.
Table:
 | Number of Options | Weighted average exercise price | Weighted average remaining contractual life (years) | Aggregate intrinsic value $
Outstanding, January 1, 2018 | 1,368,772 | $3.12 |  | 
Granted – 2018 | 401,099 | $9.27 |  | 
Exercised – 2018 | (165,169) | $3.16 |  | 
Expired – 2018 | (50,002) | $5.48 |  | 
Outstanding, December 31, 2018 | 1,554,700 | $4.63 | 3.0 | 
Granted – 2019 | 410,134 | $12.28 |  | 
Exercised – 2019 | (251,063) | $3.73 |  | 
Expired – 2019 | (89,550) | $12.55 |  | 
Outstanding, December 31, 2019 | 1,624,221 | $6.27 | 2.6 | $7,925,643
Exercisable, December 31, 2019 | 1,143,637 | $4.39 | 1.9 | $7,197,053


Question: What is the proportion of exercisable options over outstanding options for the year ended in December 31, 2019?
Answer: 0.7
Calculation: 1,143,637/1,624,221
Item 6. Selected Consolidated Financial Data
The following table presents selected consolidated financial data as of and for the five-year period ended December 31, 2019. Our past results of operations are not necessarily indicative of our future results of operations. The following selected consolidated financial data is qualified in its entirety by, and should be read in conjunction with, “Management's Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements and the notes thereto included elsewhere herein.
Consolidated Balance Sheet Data:
Table:
 |  |  | As of December 31, |  | 
 | 2019 | 2018 | 2017 | 2016 | 2015
 |  |  | (In thousands) |  | 
Cash and cash equivalents | $19,505 | $18,017 | $22,553 | $26,838 | $35,128
Working capital | $1,116 | $6,356 | $7,646 | $14,643 | $16,046
Total assets | $54,538 | $43,424 | $45,672 | $53,530 | $68,579
Stockholders' equity | $10,863 | $14,059 | $13,078 | $18,064 | $21,387


Question: What is the average value of working capital from 2015 to 2019?
Answer: 9161.4
Calculation: (1,116+ 6,356+ 7,646+ 14,643+16,046)/5
Results of Operations
Historically, revenues and earnings may or may not be representative of future operating results due to various economic and other factors. The following table sets forth the Consolidated Statements of Operations for the periods indicated (amounts in thousands):
(1) Fiscal years ended March 31, 2018 and 2017 adjusted due to the adoption of ASC 606.
Table:
 |  | Fiscal Years Ended March 31, | 
 | 2019 | 2018 | 2017
Net sales (1) | $1,382,818 | $1,200,181 | $757,338
Operating costs and expenses: |  |  | 
Cost of sales (1) | 924,276 | 860,744 | 571,944
Selling, general and administrative expenses | 202,642 | 173,620 | 107,658
Research and development (1) | 44,612 | 39,114 | 26,693
Restructuring charges | 8,779 | 14,843 | 5,404
(Gain) loss on write down and disposal of long-lived assets | 1,660 | (992) | 10,671
Total operating costs and expenses | 1,181,969 | 1,087,329 | 722,370
Operating income (1) | 200,849 | 112,852 | 34,968
Non-operating (income) expense: |  |  | 
Interest income | (2,035) | (809) | (24)
Interest expense | 21,239 | 32,882 | 39,755
Acquisition (gain) loss | — | (130,880) | —
Change in value of TOKIN options | — | — | (10,700)
Other (income) expense, net (1) | 11,214 | 24,592 | (3,871)
Income before income taxes and equity income (loss) from equity method investments (1) | 170,431 | 187,067 | 9,808
Income tax expense (benefit) (1) | (39,460) | 9,132 | 4,294
Income before equity income (loss) from equity method investments (1) | 209,891 | 177,935 | 5,514
Equity income (loss) from equity method investments | (3,304) | 76,192 | 41,643
Net income (1) | $206,587 | $254,127 | $47,157


Question: What were the net sales in 2019?
Answer: 1,382,818
15. Revenue from Contracts with Customers
Impact of Adopting Topic 606
The Company adopted Topic 606 at the beginning of fiscal 2019 using the modified retrospective method. The new standard resulted in a change to the timing of revenue recognition for a significant portion of the Company's revenue, whereby revenue is recognized over time, as products are produced, as opposed to at a point in time based upon shipping terms. As a result of the adoption of Topic 606, the following adjustments were made to the opening balances of the Company's Consolidated Balance Sheets (in thousands):
The cumulative effect of applying the new guidance in Topic 606 resulted in the Company increasing its fiscal 2019 opening Retained earnings balance by$ 7.8 million due to certain customer contracts requiring revenue recognition over time. Contract assets in the amount of$ 76.4 million were recognized due to the recognition of revenue on an over time basis for some customers rather than at a specific point in time. Inventory declined $69.0 million primarily due to earlier recognition of costs related to the contracts for which revenue was recognized on an over time basis. The decline in other accrued liabilities is primarily due to the reclassification of deferred revenue to contract assets for prepayments associated with revenue recognized over time, partially offset by an increase in taxes payable associated with the increase in revenue recognized over time.
Table:
 | Balance at September 29, 2018  | Impacts due to adoption of Topic
606 | Balance at September 30, 2018
ASSETS |  |  | 
   Contract assets | $— | $76,417 | $76,417
   Inventories | 794,346 | (68,959) | 725,387
LIABILITIES AND SHAREHOLDERS' EQUITY |  |  | 
   Other accrued liabilities | $68,163 | $(357) | $67,806
   Retained earnings | 1,062,246 | 7,815 | 1,070,061


Question: What was the balance of Inventories before adoption of Topic 606?
Answer: 794,346
NOTE 14. PROVISION FOR WARRANTY
The changes in the amount of provision for warranty are as follows:
Costs of warranty include the cost of labor and materials to repair a product during the warranty period. The main term of the warranty period is one year. The Company accrues for the estimated cost of the warranty on its products shipped in the provision for warranty, upon recognition of the sale of the product. The costs are estimated based on actual historical expenses incurred and on estimated future expenses related to current sales, and are updated periodically. Actual warranty costs are charged against the provision for warranty.
Table:
 | December 31, | 
 | 2018 | 2019
Balance January 1 | 6,562 | 7,955
Charged to cost of sales | 18,408 | 26,301
Deductions | (8,985) | (12,232)
Releases of expired warranty | (8,214) | (5,684)
Foreign currency translation effect | 184 | 84
Balance December 31 | 7,955 | 16,424


Question: For what years are the costs of warranty information provided?
Answer: 2018, 2019
The Company has adopted five share option schemes, namely, the Pre-IPO Option Scheme, the Post-IPO Option Scheme I, the Post-IPO Option Scheme II, the Post-IPO Option Scheme III and the Post-IPO Option Scheme IV. The Pre-IPO Option Scheme, the Post-IPO Option Scheme I, the Post-IPO Option Scheme II and the Post-IPO Option Scheme III expired on 31 December 2011, 23 March 2014, 16 May 2017 and 13 May 2019 respectively.
As at 31 December 2019, there were a total of 20,722,380 outstanding share options granted to a director of the Company, details of which are as follows:
1. For options granted with exercisable date determined based on the grant date of options, the first 20% of the total options can be exercised 1 year after the grant date, and each 20% of the total options will become exercisable in each subsequent year.
2. For options granted with exercisable date determined based on the grant date of options, the first 25% of the total options can be exercised 1 year after the grant date, and each 25% of the total options will become exercisable in each subsequent year.
3. The closing price immediately before the date on which the options were granted on 4 April 2019 was HKD378.
4. No options were cancelled or lapsed during the year.
Table:
 |  |  | Number of share options |  |  |  | 
Name of director | Date of grant | As at 1 January 2019 | Granted during the year | Exercised during the year | As at 31 December 2019 | Exercise price | Exercise period
 |  |  |  |  |  | HKD | 
Lau Chi Ping Martin | 25 March 2014 | 5,000,000 | - | - | 5,000,000 | 114.52 | 25 March 2015 to 24 March 2021 (Note 2)
 | 21 March 2016 | 3,750,000 | - | - | 3,750,000 | 158.10 | 21 March 2017 to 20 March 2023 (Note 2)
 | 24 March 2017 | 5,250,000 | - | - | 5,250,000 | 225.44 | 24 March 2018 to 23 March 2024 (Note 2)
 | 9 April 2018 | 3,215,800 | - | - | 3,215,800 | 410.00 | 9 April 2019 to 8 April 2025 (Note 2)
 | 4 April 2019 | - | 3,506,580 (Note 3) | - | 3,506,580 | 376.00 | 4 April 2020 to 3 April 2026 (Note 2)
 | Total: | 17,215,800 | 3,506,580 | - | 20,722,380 |  | 


Question: How many share option schemes has the Company adopted?
Answer: five
The reconciliation of income tax computed at the U.S. federal statutory tax rate to income tax expense is as follows:
(1) In 2018, we recorded $3.5 million of tax expense related to foreign earnings which were not permanently reinvested prior to the enactment of the U.S. Tax Act. After enactment, certain foreign earnings are taxed at higher statutory rates than the U.S. which results in $2.1 million of incremental tax expense in 2019. In 2017, we provided for deferred taxes on all cumulative unremitted foreign earnings, as the earnings were no longer considered permanently reinvested resulting in a charge of $9.5 million.
Table:
 |  | Years Ended September 30, | 
 | 2019 | 2018 | 2017
 |  | (in thousands) | 
Tax expense at U.S. statutory rate | $ 10,992 | $  3,124 | $  (3,877)
State income taxes, net of federal tax effect | 1,416 | (237) | (923)
Nondeductible expenses | 1,720 | 1,186 | (185)
Change in reserve for tax contingencies | (1,468) | (1,047) | (4,435)
Change in deferred tax asset valuation allowance | (10,007) | 8,784 | 17,374
Foreign rate differential (1) | 2,149 | 5,684 | 9,912
Tax credits | (4,767) | (2,656) | (3,459)
Impact of U.S. Tax Reform | — | (7,053) | —
Global Intangible Low-Tax Income | 8,182 | — | —
Stock Based Compensation | (448) | 59 | 16
Non-controlling interest in equity arrangements | 1,802 | 99 | —
Other | 1,469 | (850) | 235
Provision for income taxes | $  11,040 | $  7,093 | $  14,658


Question: What is the change in nondeductible expenses in 2019 from 2018?
Answer: 534
Calculation: 1,720-1,186
We do not allocate to our operating segments certain operating expenses that we manage separately at the corporate level and are not used in evaluating the results of, or in allocating resources to, our segments. These unallocated expenses consist primarily of stock-based compensation expense; amortization of intangible assets; restructuring, transition and other costs; and acquisition-related costs.
The following table provides a reconciliation of our total reportable segments’ operating income to our total operating income (loss):
Table:
 |  | Year Ended | 
(In millions) | March 29, 2019 | March 30, 2018 | March 31, 2017
Total segment operating income | $1,414 | $1,584 | $1,026
Reconciling items: |  |  | 
Stock-based compensation expense | 352 | 610 | 440
Amortization of intangible assets | 443 | 453 | 293
Restructuring, transition and other costs | 241 | 410 | 273
Acquisition-related costs | 3 | 60 | 120
Other | (5) | 2 | -
Total consolidated operating income (loss) from continuing operations | $380 | $49 | $(100)


Question: What does this table show?
Answer: reconciliation of our total reportable segments’ operating income to our total operating income (loss)
Option Exercises and Stock Vested in 2018
The following table sets forth the number of shares of common stock acquired during 2018 by our named executive officers upon the exercise of stock options or upon the vesting of RSUs or RSAs, as well as the value realized upon such equity award transactions.
(1) Calculated by multiplying (i) the fair market value of Class A common stock on the vesting date, which was determined using the closing price on the New York Stock Exchange of a share of Class A common stock on the date of vest, or if such day is a holiday, on the immediately preceding trading day less the option exercise price paid for such shares of common stock, by (ii) the number of shares of common stock acquired upon exercise.
(2) Reflects the aggregate number of shares of Class A common stock underlying RSUs and RSAs that vested in 2018. Of the amount shown for Messrs. Daswani and Murphy and Mses. Friar, Henry, Reses and Whiteley, 20,132, 6,741, 44,857, 59,014, 91,306 and 17,217 shares, respectively, of Class A common stock were withheld to cover tax withholding obligations upon vesting.
(3) Calculated by multiplying (i) the fair market value of Class A common stock on the vesting date, which was determined using the closing price on the New York Stock Exchange of a share of common stock on the date of vest, or if such day is a holiday, on the immediately preceding trading day, by (ii) the number of shares of common stock acquired upon vesting. Of the amount shown for Messrs. Daswani and Murphy and Mses. Friar, Henry, Reses and Whiteley, $1,389,704, $414,596, $2,782,628, $3,619,149, $5,502,076 and $1,114,287, respectively, represents the value of shares withheld to cover tax withholding obligations upon vesting.
Table:
 | Option Awards |  | Stock Awards | 
Name | Number of Shares Acquired on Exercise (#) | Number of Value Realized on Exercise ($)(1) | Shares Acquired on Vesting of RSUs and RSAs (#) (2) | Value Realized on Vesting of RSUs and RSAs ($) (3)
Mr. Dorsey | — | — | — | —
Ms. Friar | 1,082,343 | 54,631,297 | 95,889 | 5,788,657
Ms. Henry | 200,000 | 13,187,645 | 124,498 | 7,475,787
Ms. Reses | — | — | 189,577 | 11,284,454
Ms. Whiteley | 20,625 | 989,821 | 38,156 | 2,375,984
Mr. Daswani | — | — | 45,310 | 3,106,268
Mr. Murphy | — | — | 18,024 | 1,120,072


Question: What does the Number of Shares Acquired on Vesting of RSUs and RSAs column show?
Answer: Reflects the aggregate number of shares of Class A common stock underlying RSUs and RSAs that vested in 2018.
Foreign Currency Translation Impact on Consolidated Financial Results
Since we are a U.S. domiciled company, we translate our foreign currency-denominated financial results into US Dollars. Due to the changes in the value of foreign currencies relative to the US Dollar, translating our financial results from foreign currencies to US Dollars may result in a favorable or unfavorable impact. Historically, the most significant currencies that have impacted the translation of our consolidated financial results are the euro, the Australian dollar, the Mexican peso, the British pound, the Canadian dollar, the Brazilian real and the Chinese Renminbi.
The following table presents the approximate favorable or (unfavorable) impact foreign currency translation had on certain of our consolidated financial results
Table:
(In millions) | 2019 vs. 2018 | 2018 vs. 2017
Net sales | $ (137.2) | $ (43.4)
Cost of sales | 98.4 | 31.7
Selling, general and administrative expenses | 16.3 | 1.0
Net earnings | (15.7) | (8.2)
Non-U.S. GAAP Adjusted EBITDA | (25.3) | (11.1)


Question: What does the table show?
Answer: The following table presents the approximate favorable or (unfavorable) impact foreign currency translation had on certain of our consolidated financial results
18. Trade and other receivables
Following the application of IFRS 16, trade and other receivables have been restated (note 2).
Trade receivables are amounts due from customers for services performed in the ordinary course of business. They are generally due for settlement within 30 days and therefore are all classified as current. Trade receivables are recognised initially at the amount of consideration that is unconditional and has been invoiced at the reporting date. The Group holds the trade receivables with the objective to collect the contractual cash flows and therefore measures them subsequently at amortised cost using the effective interest method.
Accrued income relates to the Group’s rights to consideration for services provided but not invoiced at the reporting date. Accrued income is transferred to receivables when invoiced. Other receivables include £0.1m due from Auto Trader Auto Stock Limited, a related party (note 34).
Exposure credit risk and expected credit losses relating to trade and other receivables are disclosed in note 31.
Table:
 | 2019 | (Restated) 2018
 | £m | £m
Trade receivables | 27.0 | 28.8
Less: provision for impairment of trade receivables | (2.1) | (3.4)
Net trade receivables | 24.9 | 25.4
Accrued income | 28.0 | 26.7
Prepayments | 2.9 | 2.7
Other receivables | 0.3 | 0.1
Total | 56.1 | 54.9


Question: What are trade receivables?
Answer: amounts due from customers for services performed in the ordinary course of business